Narrative review of management strategies and outcomes in node-positive prostate cancer.

ABSTRACT: Pelvic nodal involvement is present in 13% of new prostate cancer diagnoses each year and is associated with a poor prognosis compared to localized disease. Grouped as stage IV along with distant metastatic disease, node-positive nonmetastatic patients historically received systemic therapy alone as primary treatment. This treatment paradigm has shifted as data have demonstrated that these patients may benefit from aggressive locoregional therapy and are potentially curable. There is currently a lack of randomized evidence to define the optimal management for node-positive patients. While a few trials have included node-positive patients, the majority of data are derived from large multi-institutional series or population-based series. This narrative review summarizes the current literatur

SUBMITTER: D'Rummo KA 

PROVIDER: S-EPMC8350237 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature